Studies have shown that inactivation or mutations of Lpl could lead to the occurrence of a variety of diseases [37, 38], such as hypertriglyceridemia and acute pancreatitis [39], prostate cancer [40], Alzheimer’s disease [41] and so on. This evidence concerns the gene LPL and early-onset autosomal dominant Alzheimer disease.